Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion type Assertion NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_head.
- NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_provenance.
- NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion evidence source_evidence_literature NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_provenance.
- NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion SIO_000772 20534739 NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_provenance.
- NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion wasDerivedFrom befree-20150227 NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_provenance.
- NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion wasGeneratedBy ECO_0000203 NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_provenance.